alexa Gobardhan Das | University of Kwazulu-Natal
ISSN: 2161-1068

Mycobacterial Diseases
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Gobardhan Das

Gobardhan Das Gobardhan Das
Department of Human Health
University of Kwazulu-Natal
South Africa

Gobardhandas Ph.D in Institute of Microbial Technology, India. 1997, Thesis on Immunological basis of Susceptibility and Resistance in Animal Models of tuberculosis, A Special Focus on T cell Tolerance , Post Doctoral Training: Prof. Charles A Janeway laboratory at Yale University School of Medicine, Howard Hughes Medical Institute. 19972002, Interest includes Innate like lymphocytes that adjoins innate and adaptive immunity, Senior Scientist in Aventis Pharmaceuticals 20022007, Interest includes Identification and validation of druggable targets for the intervention of allergic and autoimmune diseases.

Research Interest

Gobardhan Research interests include Conventional treatment for tuberculosis involves several antibiotics, a lengthy treatment regimen with expensive drugs, and a high risk of generating drug-resistant forms of the tuberculoid organisms (M. tb). Our laboratory is interested in small molecule directed immunotherapy to promote the generation of immunocytes that provide immunity, and simultaneously inhibit disease-promoting immunocytes. To modulate these immunocytes, we are interested in identifying molecular targets in these cells. Thus, our method has three advantages over conventional antibiotic treatment: expulsion of the harbored tuberculoid organisms; generation of signature protective memory responses; and lack of selection for drug-resistant forms of tuberculosis (MDRs).


Global Speakers in the subject

Global Experts in the subject


Challenges of Tuberculosis Treatment with DOTS: An Immune Impairment Perspective
Sultan Tousif1, Shaheer Ahmad, Kuhulika Bhalla, Prashini Moodley and Gobardhan Das1
Review Article: J Cell Sci Ther
DOI: 10.4172/2157-7013.1000223
Revisiting Immunotherapy in Tuberculosis
Debapriya Bhattacharya, Ved Prakash Dwivedi and Gobardhan Das
Editorial: Mycobact Dis 2014, 4: e123
DOI: 10.4172/2161-1068.1000e123
Tuberculosis the Ancient Disease Needs Intervention of Modern Tools
Riti Saran and Gobardhan Das
Editorial: Mycobact Dis 2011, 1: e103
DOI: 10.4172/2161-1068.1000e103
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version